Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2.47M
-
Shares change
-
-21.8K
-
Total reported value, excl. options
-
$3.9M
-
Value change
-
-$10K
-
Put/Call ratio
-
0.06
-
Number of buys
-
11
-
Number of sells
-
-8
-
Price
-
$1.58
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2022
31 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q4 2022.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.47M shares
of 51.9M outstanding shares and own 4.76% of the company stock.
Largest 10 shareholders include COOPERMAN LEON G (813K shares), VANGUARD GROUP INC (783K shares), JACOB ASSET MANAGEMENT OF NEW YORK LLC (234K shares), GEODE CAPITAL MANAGEMENT, LLC (185K shares), NORTHERN TRUST CORP (93.1K shares), BlackRock Inc. (69.9K shares), STATE STREET CORP (66.6K shares), DIMENSIONAL FUND ADVISORS LP (42.6K shares), CITADEL ADVISORS LLC (39.2K shares), and Bank of New York Mellon Corp (36.1K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.